MFDS Begins Review of Janssen Korea’s COVID-19 Vaccine [Press Release Feb. 27, 2021]
- Registration Date 2021-03-04
- Hit 12604
[Press Release Feb. 27, 2021 / unofficial translation]
The Ministry of Food and Drug Safety (MFDS, Minister Kim Ganglip) has announced that on February 27, Janssen Korea (Johnson & Johnson)
filed marketing authorization application for its COVID-19 vaccine (Ad26.COV2S).
Division 국제협력담당관
Written by 김민주
Telephone 043-719-1565